Sisram Medical (SEHK:1696) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

1696 Panoramica delle azioni

1696 analisi fondamentale
Punteggio fiocco di neve
Valutazione	5/6
Crescita futura	4/6
Prestazioni passate	2/6
Salute finanziaria	5/6
Dividendi	3/6

Premi

Negoziato a 67.1% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 11.51% all'anno

Negoziato a un buon valore rispetto ai pari e al settore

Analisi del rischio

I margini di profitto (6.6%) sono inferiori rispetto allo scorso anno (10.9%)

Andamento instabile dei dividendi

Sisram Medical Ltd Concorrenti

Gaush Meditech

SEHK:2407

HK$1.5b

Acotec Scientific Holdings

SEHK:6669

HK$2.5b

PW Medtech Group

SEHK:1358

HK$1.8b

Modern Dental Group

SEHK:3600

HK$3.9b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Sisram Medical
Prezzi storici delle azioni
Prezzo attuale dell'azione	HK$4.04
Massimo di 52 settimane	HK$6.48
Minimo di 52 settimane	HK$2.75
Beta	1.37
1Variazione di 1 mese	25.86%
Variazione a 3 mesi	15.10%
Variazione di 1 anno	-35.67%
3Variazione a 3 anni	-63.07%
Variazione a 5 anni	-15.13%
Variazione dall'IPO	-50.25%

Notizie e aggiornamenti recenti

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Recent updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24

Rendimenti per gli azionisti

	1696	HK Medical Equipment	HK Mercato
7D	23.9%	24.2%	13.0%
1Y	-35.7%	-26.9%	16.1%

Ritorno vs Industria: 1696 ha avuto una performance inferiore rispetto al Hong Kong Medical Equipment che ha registrato un rendimento -44.6 % nell'ultimo anno.

Rendimento vs Mercato: 1696 ha avuto una performance inferiore al mercato Hong Kong che ha registrato un rendimento 6.2 % nell'ultimo anno.

Volatilità dei prezzi

Is 1696's price volatile compared to industry and market?
1696 volatility
1696 Average Weekly Movement	8.6%
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	7.1%
10% most volatile stocks in HK Market	14.7%
10% least volatile stocks in HK Market	3.6%

Prezzo delle azioni stabile: Il prezzo delle azioni di 1696 è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 6% ) di 1696 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2013	1,026	Lior Dayan	www.sisram-medical.com

Sisram Medical Ltd si occupa di ricerca, progettazione, sviluppo, produzione e vendita di apparecchiature mediche estetiche e dentali, dispositivi per uso domestico, prodotti iniettabili e cosmeceutici in Asia Pacifico, Europa, Nord America, America Latina, Medio Oriente e Africa. L'azienda offre un portafoglio di prodotti e trattamenti per vari settori del benessere, tra cui depilazione, ringiovanimento della pelle, acne e cicatrici da acne, rimodellamento del corpo e del viso, pigmentazione e skin resurfacing, innesto di grasso, filler dermici per il viso, prodotti iniettabili per il rimodellamento del tessuto cutaneo, cura della persona e odontoiatria estetica, veicolazione trans epidermica, trattamento della cellulite, smagliature, lesioni vascolari e pigmentate, idradermabrasione, blefaroplastica - lifting non chirurgico delle palpebre, liposuzione, salute femminile e riabilitazione sessuale. L'azienda produce, distribuisce e vende anche apparecchiature mediche.

Sisram Medical Ltd Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Sisram Medical con la sua capitalizzazione di mercato?
1696 statistiche fondamentali
Capitalizzazione di mercato	HK$1.89b
Guadagni(TTM)	HK$182.92m
Ricavi(TTM)	HK$2.77b

10.3x

Rapporto P/E

0.7x

Rapporto P/S

1696 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
1696 Conto economico (TTM)
Ricavi	US$356.40m
Costo del fatturato	US$136.86m
Profitto lordo	US$219.54m
Altre spese	US$195.99m
Guadagni	US$23.55m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	0.05
Margine lordo	61.60%
Margine di profitto netto	6.61%
Rapporto debito/patrimonio netto	1.1%

Come si è comportato 1696 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

3.9%

Rendimento attuale del dividendo

40%

Rapporto di remunerazione

1696 Panoramica delle azioni

Premi

Analisi del rischio

Sisram Medical Ltd Concorrenti

SEHK:2407

HK$1.5b

SEHK:6669

HK$2.5b

SEHK:1358

HK$1.8b

SEHK:3600

HK$3.9b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Investor sentiment improves as stock rises 24%

Sisram Medical Ltd Receives Product Approval from the National Medical Products Administration

First half 2024 earnings released: EPS: US$0.023 (vs US$0.04 in 1H 2023)

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Recent updates

Investor sentiment improves as stock rises 24%

Sisram Medical Ltd Receives Product Approval from the National Medical Products Administration

First half 2024 earnings released: EPS: US$0.023 (vs US$0.04 in 1H 2023)

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Sisram Medical Ltd Declares A Final Dividend, Payable on or Around 9 September 2024

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Sisram Medical Ltd, Annual General Meeting, Jun 24, 2024

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Investor sentiment deteriorates as stock falls 20%

Now 21% overvalued

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Sisram Medical Ltd Announces the Registration Application of Profhilo

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 19%

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

First half 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1H 2022)

Upcoming dividend of HK$0.17 per share at 2.3% yield

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023

Sisram Medical Announces the Launch of Alma Veil for the U.S. Market

Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 16%

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Sisram Medical Ltd, Annual General Meeting, Jun 28, 2023

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: US$0.086 (vs US$0.069 in FY 2021)

Investor sentiment deteriorates as stock falls 16%

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 19%

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023

Investor sentiment improved over the past week

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Investor sentiment improved over the past week

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Less than half of directors are independent

Investor sentiment improved over the past week

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Sisram Medical Ltd Provides Revenue Guidance for the Year 2022

First half 2022 earnings released: EPS: US$0.044 (vs US$0.037 in 1H 2021)